Tyrosinase precursor (1-9)

Tyrosinase precursor (1-9) is a synthetic peptide fragment corresponding to the N-terminal sequence of the tyrosinase enzyme precursor. As a short peptide derived from a key region of the tyrosinase zymogen, it represents a valuable tool for investigating the biosynthesis, processing, and functional regulation of tyrosinase, an enzyme central to melanin production and various oxidative biochemical pathways. The peptide's defined sequence and structural properties make it particularly relevant for studies focused on enzyme maturation, post-translational modification, and protein-protein interactions associated with pigment biosynthesis and cellular oxidative processes.

Peptide biochemistry research: Tyrosinase precursor (1-9) serves as a model substrate in the study of peptide processing and maturation mechanisms within the tyrosinase family. Researchers utilize this fragment to examine the enzymatic cleavage events and molecular recognition patterns that govern the conversion of the inactive precursor to the active tyrosinase enzyme. By providing a defined segment of the pro-enzyme, the peptide enables detailed analysis of the structural determinants required for proteolytic activation, advancing understanding of the regulatory checkpoints in melanogenic pathways.

Enzyme-substrate interaction studies: The N-terminal peptide sequence is instrumental in elucidating the molecular interactions between tyrosinase and its regulatory partners. Through in vitro binding assays and structural studies, this fragment facilitates the mapping of recognition sites that mediate the association of tyrosinase with chaperones, inhibitors, or other modulators during biosynthetic trafficking. Such investigations are crucial for clarifying the mechanisms that underlie enzyme localization, stability, and function within the secretory pathway.

Antibody production and epitope mapping: As a synthetic peptide representing a specific region of the tyrosinase precursor, this fragment is widely applied in the generation of polyclonal or monoclonal antibodies targeting the N-terminal epitope. These antibodies are invaluable tools for immunodetection, localization, and quantification of tyrosinase or its precursor forms in cell lysates, tissue extracts, or biochemical assays. Furthermore, the peptide is used in epitope mapping studies to identify antibody binding sites, supporting the development of highly specific immunoreagents for research applications.

Peptide synthesis and analytical method development: The well-defined sequence of tyrosinase precursor (1-9) makes it a suitable standard or reference in peptide synthesis optimization and analytical method validation. Researchers employ this fragment to calibrate chromatographic systems, assess peptide purity, and refine mass spectrometric protocols for the detection and quantification of related peptides. Its application in these contexts supports the advancement of robust analytical workflows in proteomics and peptide chemistry laboratories.

Functional studies of melanogenesis regulation: By incorporating this peptide into cellular or biochemical assays, investigators can probe the impact of N-terminal modifications, truncations, or sequence variations on tyrosinase activity and melanin biosynthesis. Such studies shed light on the structure-function relationships that dictate enzyme activation and pigment production, contributing to a deeper understanding of the molecular basis for pigmentation disorders, oxidative stress responses, and related biological phenomena.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry